<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:a6cf088c-e54c-4ffd-b839-41926fb0966e,g:4ff84466-72ad-4f3e-be53-c78a1eb796c9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mdgl-20240930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_1a59e647-1c67-42b3-ba74-9d99dd56df3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2f4bb188-11ed-490a-91d6-40cfc66a9c65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_1a59e647-1c67-42b3-ba74-9d99dd56df3c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2f4bb188-11ed-490a-91d6-40cfc66a9c65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c81f6f02-8a4b-4816-8634-d9dc7d3fb525" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_1a59e647-1c67-42b3-ba74-9d99dd56df3c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c81f6f02-8a4b-4816-8634-d9dc7d3fb525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_00d32f16-006b-44e3-8069-0c34490019ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_91d863b1-ae29-4275-baef-895bc2481039" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_00d32f16-006b-44e3-8069-0c34490019ce" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_91d863b1-ae29-4275-baef-895bc2481039" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f379c720-7cfc-4ae0-a1c2-0ebab53c4bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_00d32f16-006b-44e3-8069-0c34490019ce" xlink:to="loc_us-gaap_LiabilitiesCurrent_f379c720-7cfc-4ae0-a1c2-0ebab53c4bc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_66fd8a80-0c6a-4f46-bc51-af422e3e263a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_91280504-67b0-4f32-9167-47c889617f80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_66fd8a80-0c6a-4f46-bc51-af422e3e263a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_91280504-67b0-4f32-9167-47c889617f80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_a8162fce-3104-417c-b43c-76246fa81867" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_66fd8a80-0c6a-4f46-bc51-af422e3e263a" xlink:to="loc_us-gaap_RestrictedCash_a8162fce-3104-417c-b43c-76246fa81867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_983129ed-0cbe-403a-8291-ccc82b8c5f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_66fd8a80-0c6a-4f46-bc51-af422e3e263a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_983129ed-0cbe-403a-8291-ccc82b8c5f8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a3525459-07c7-40e4-89e5-4d85b5028405" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_66fd8a80-0c6a-4f46-bc51-af422e3e263a" xlink:to="loc_us-gaap_InventoryNet_a3525459-07c7-40e4-89e5-4d85b5028405" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d4b3af57-3424-4007-864f-bc046b281bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_66fd8a80-0c6a-4f46-bc51-af422e3e263a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d4b3af57-3424-4007-864f-bc046b281bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_00232bf0-2d27-40b7-9bc9-1a377b55f7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_66fd8a80-0c6a-4f46-bc51-af422e3e263a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_00232bf0-2d27-40b7-9bc9-1a377b55f7e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6e416238-6256-4608-8c78-1428322741dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_53e05d1e-2012-45f8-8506-dc7d142d0c72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6e416238-6256-4608-8c78-1428322741dc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_53e05d1e-2012-45f8-8506-dc7d142d0c72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ab1b211f-dbb9-43f5-827d-0cd6327f1003" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6e416238-6256-4608-8c78-1428322741dc" xlink:to="loc_us-gaap_AccountsPayableCurrent_ab1b211f-dbb9-43f5-827d-0cd6327f1003" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_618f67c2-c450-4420-9e69-57eb1a2f49d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6e416238-6256-4608-8c78-1428322741dc" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_618f67c2-c450-4420-9e69-57eb1a2f49d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_51ba1675-5b45-409a-99c6-5e268fbe5403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_80c38e12-f958-4ad2-a504-e17603dbc466" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_51ba1675-5b45-409a-99c6-5e268fbe5403" xlink:to="loc_us-gaap_StockholdersEquity_80c38e12-f958-4ad2-a504-e17603dbc466" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9a03d588-804a-477c-b270-c66394016dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_51ba1675-5b45-409a-99c6-5e268fbe5403" xlink:to="loc_us-gaap_Liabilities_9a03d588-804a-477c-b270-c66394016dbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_07229229-6cb4-47de-91d0-295b4cb98ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7e4e1d9e-39c0-413e-a9c1-f1059ee5824a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_07229229-6cb4-47de-91d0-295b4cb98ec0" xlink:to="loc_us-gaap_CommonStockValue_7e4e1d9e-39c0-413e-a9c1-f1059ee5824a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_91e5369d-35dc-4f9e-8c4b-ebcadca0f6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_07229229-6cb4-47de-91d0-295b4cb98ec0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_91e5369d-35dc-4f9e-8c4b-ebcadca0f6f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_eb8f6abf-21f1-4726-b61c-a0d31870044c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_07229229-6cb4-47de-91d0-295b4cb98ec0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_eb8f6abf-21f1-4726-b61c-a0d31870044c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f53c3fc1-7395-4cb8-8a4c-e9096588758d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_07229229-6cb4-47de-91d0-295b4cb98ec0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f53c3fc1-7395-4cb8-8a4c-e9096588758d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a9f5eab6-945e-44d6-84af-4bb3975e5095" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_07229229-6cb4-47de-91d0-295b4cb98ec0" xlink:to="loc_us-gaap_PreferredStockValue_a9f5eab6-945e-44d6-84af-4bb3975e5095" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_236f0c1d-5845-4f2f-8346-06f9f494c5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ded1dad5-2bc0-4e6e-886a-5d13ed0356a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_236f0c1d-5845-4f2f-8346-06f9f494c5dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ded1dad5-2bc0-4e6e-886a-5d13ed0356a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5693a5a9-076f-4d40-b479-761d2d6e1ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_236f0c1d-5845-4f2f-8346-06f9f494c5dc" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5693a5a9-076f-4d40-b479-761d2d6e1ca8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6dcab781-f95c-4189-b347-fbbdc1deb120" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_236f0c1d-5845-4f2f-8346-06f9f494c5dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6dcab781-f95c-4189-b347-fbbdc1deb120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_733c9d51-0f67-4dfe-b678-7f07b837079c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_236f0c1d-5845-4f2f-8346-06f9f494c5dc" xlink:to="loc_us-gaap_AssetsCurrent_733c9d51-0f67-4dfe-b678-7f07b837079c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mdgl-20240930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_79a78520-48b4-457d-b218-f61bca671e04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11367354-8ef6-4810-adaa-4004298fa40f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_79a78520-48b4-457d-b218-f61bca671e04" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11367354-8ef6-4810-adaa-4004298fa40f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_fbbbb1b2-f5da-4357-8602-c0d0a9f78e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_79a78520-48b4-457d-b218-f61bca671e04" xlink:to="loc_us-gaap_OperatingExpenses_fbbbb1b2-f5da-4357-8602-c0d0a9f78e5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3713a459-c838-49ef-989c-817f5bcd54c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_18beccaf-d945-4cf0-9429-11454bad7d41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3713a459-c838-49ef-989c-817f5bcd54c8" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_18beccaf-d945-4cf0-9429-11454bad7d41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_95d16b83-dd50-4d49-b51d-08c17e7f6a16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3713a459-c838-49ef-989c-817f5bcd54c8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_95d16b83-dd50-4d49-b51d-08c17e7f6a16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_d2fda0e1-a82f-4018-af7b-f3170c06d25a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3713a459-c838-49ef-989c-817f5bcd54c8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_d2fda0e1-a82f-4018-af7b-f3170c06d25a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_85747160-047d-4da7-83c2-603cb939c49c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9c2920f2-b50e-42c0-8993-385bce4d0a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_85747160-047d-4da7-83c2-603cb939c49c" xlink:to="loc_us-gaap_InterestExpense_9c2920f2-b50e-42c0-8993-385bce4d0a3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0909fbb2-b4a5-4df9-905e-2bcf8389abc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_85747160-047d-4da7-83c2-603cb939c49c" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0909fbb2-b4a5-4df9-905e-2bcf8389abc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c75663b3-405a-4738-ae6a-c2b19350940f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_85747160-047d-4da7-83c2-603cb939c49c" xlink:to="loc_us-gaap_OperatingIncomeLoss_c75663b3-405a-4738-ae6a-c2b19350940f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="mdgl-20240930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_58386de6-de9f-44f5-b6b9-e82e570b31c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_05519ec1-f7d6-46f6-b518-63dcd7b7e6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_58386de6-de9f-44f5-b6b9-e82e570b31c5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_05519ec1-f7d6-46f6-b518-63dcd7b7e6c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d024fe9c-efc6-42bb-a0e6-6339648080d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_58386de6-de9f-44f5-b6b9-e82e570b31c5" xlink:to="loc_us-gaap_NetIncomeLoss_d024fe9c-efc6-42bb-a0e6-6339648080d6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mdgl-20240930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_746271f3-b868-4aa8-ab07-d871b13767cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_119a7a0c-331e-4bd5-a404-c24cc2959246" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_746271f3-b868-4aa8-ab07-d871b13767cd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_119a7a0c-331e-4bd5-a404-c24cc2959246" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fbd6fb8e-d243-40e5-9ca5-28fa8f86c8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_746271f3-b868-4aa8-ab07-d871b13767cd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fbd6fb8e-d243-40e5-9ca5-28fa8f86c8ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1fb5b4bd-6da7-4933-b4c7-384a9323d885" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_746271f3-b868-4aa8-ab07-d871b13767cd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1fb5b4bd-6da7-4933-b4c7-384a9323d885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca76b515-b429-4d5c-b5d9-f1c1fbfc3616" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_462bbfbd-e374-4942-a98e-f96bd81046e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca76b515-b429-4d5c-b5d9-f1c1fbfc3616" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_462bbfbd-e374-4942-a98e-f96bd81046e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromBankDebt_f7c72314-e7a3-42b8-9422-b7393aef8d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromBankDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca76b515-b429-4d5c-b5d9-f1c1fbfc3616" xlink:to="loc_us-gaap_ProceedsFromBankDebt_f7c72314-e7a3-42b8-9422-b7393aef8d2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_b806beae-b5af-4edd-a70f-7c7b8e86fe65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca76b515-b429-4d5c-b5d9-f1c1fbfc3616" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_b806beae-b5af-4edd-a70f-7c7b8e86fe65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_00dd40f7-01f8-46ae-bac4-616553d986e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_00dd40f7-01f8-46ae-bac4-616553d986e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_11dd7c31-94d8-47a4-a64b-c2b2b396481c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_11dd7c31-94d8-47a4-a64b-c2b2b396481c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_IncreaseDecreaseInAccruedInterestNetOfInterestReceived_fdef86af-46e9-4662-ab07-eb56a401173a" xlink:href="mdgl-20240930.xsd#mdgl_IncreaseDecreaseInAccruedInterestNetOfInterestReceived"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:to="loc_mdgl_IncreaseDecreaseInAccruedInterestNetOfInterestReceived_fdef86af-46e9-4662-ab07-eb56a401173a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b06deecf-0038-44fa-a512-dca1624ec4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b06deecf-0038-44fa-a512-dca1624ec4a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d6732471-28cf-46f8-8aec-08a1248b4d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d6732471-28cf-46f8-8aec-08a1248b4d8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1662e91b-f5bb-4c75-af9a-4e950dd57b05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:to="loc_us-gaap_ProfitLoss_1662e91b-f5bb-4c75-af9a-4e950dd57b05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3b0f2cc7-9186-4f2a-ba58-37621b8cc5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3b0f2cc7-9186-4f2a-ba58-37621b8cc5a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e2ca7003-0dbe-4e1d-bfc2-8c5d00e39ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:to="loc_us-gaap_ShareBasedCompensation_e2ca7003-0dbe-4e1d-bfc2-8c5d00e39ce3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d5824324-991a-4c94-8d23-13d3588110dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d5824324-991a-4c94-8d23-13d3588110dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7c531e04-aa48-4da6-a987-647b5b83d2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7c531e04-aa48-4da6-a987-647b5b83d2e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_OperatingLeaseRightOfUseAssetPeriodicReductionIncrease_bbf26938-ec25-4d97-b89c-c750a4393f03" xlink:href="mdgl-20240930.xsd#mdgl_OperatingLeaseRightOfUseAssetPeriodicReductionIncrease"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e9dc9f-a327-40c7-8db4-237c63b1a89b" xlink:to="loc_mdgl_OperatingLeaseRightOfUseAssetPeriodicReductionIncrease_bbf26938-ec25-4d97-b89c-c750a4393f03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_670b8f64-daa6-4c5b-bf7c-98ab89da3ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b4c6073a-cf29-4adf-97ab-d7d56841255c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_670b8f64-daa6-4c5b-bf7c-98ab89da3ce6" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b4c6073a-cf29-4adf-97ab-d7d56841255c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_70f35796-30b3-416d-a947-99b698393cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_670b8f64-daa6-4c5b-bf7c-98ab89da3ce6" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_70f35796-30b3-416d-a947-99b698393cb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_b56b6338-7cdf-43e3-b9e4-67600912926c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_670b8f64-daa6-4c5b-bf7c-98ab89da3ce6" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_b56b6338-7cdf-43e3-b9e4-67600912926c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9ee609b6-f863-4764-939a-e1c385d4d507" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_670b8f64-daa6-4c5b-bf7c-98ab89da3ce6" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9ee609b6-f863-4764-939a-e1c385d4d507" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="mdgl-20240930.xsd#CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_9eda9a5b-62b6-42c7-854b-2865744775ef" xlink:href="mdgl-20240930.xsd#mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_17f93608-3028-4110-888c-eb9e251d55ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_9eda9a5b-62b6-42c7-854b-2865744775ef" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_17f93608-3028-4110-888c-eb9e251d55ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_395c2f6a-219d-4f0a-a382-16577524a963" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_9eda9a5b-62b6-42c7-854b-2865744775ef" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_395c2f6a-219d-4f0a-a382-16577524a963" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d778c51-dcf7-4950-a5e3-4129fb9e26fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f6a05f82-61a0-41cf-b220-7679550a3d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d778c51-dcf7-4950-a5e3-4129fb9e26fa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f6a05f82-61a0-41cf-b220-7679550a3d7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e2ddd1c4-b002-481f-8897-2fe5ef5046c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d778c51-dcf7-4950-a5e3-4129fb9e26fa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e2ddd1c4-b002-481f-8897-2fe5ef5046c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6943627d-d1f9-481e-b0ea-19a1c22a8064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0d778c51-dcf7-4950-a5e3-4129fb9e26fa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6943627d-d1f9-481e-b0ea-19a1c22a8064" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails_1" xlink:type="simple" xlink:href="mdgl-20240930.xsd#CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_8ba2d28c-e72e-4f7c-93d7-b23207cd0652" xlink:href="mdgl-20240930.xsd#mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_355a5fe9-c6d8-457f-8191-d589ada9013e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_8ba2d28c-e72e-4f7c-93d7-b23207cd0652" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_355a5fe9-c6d8-457f-8191-d589ada9013e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_fd66a7e9-98cd-483d-acb6-f3d17d854921" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_8ba2d28c-e72e-4f7c-93d7-b23207cd0652" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_fd66a7e9-98cd-483d-acb6-f3d17d854921" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_19233b55-4a12-423b-96b1-a21fa64f4e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_8ba2d28c-e72e-4f7c-93d7-b23207cd0652" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_19233b55-4a12-423b-96b1-a21fa64f4e3e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/InventoryDetails" xlink:type="simple" xlink:href="mdgl-20240930.xsd#InventoryDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e903c819-46f4-4e43-9447-b811e0ef64a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_197fe204-8110-4151-86e2-f81e4a238dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e903c819-46f4-4e43-9447-b811e0ef64a9" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_197fe204-8110-4151-86e2-f81e4a238dc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_185ed60a-656e-44da-aedf-be172687c6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e903c819-46f4-4e43-9447-b811e0ef64a9" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_185ed60a-656e-44da-aedf-be172687c6d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_16b24794-3aea-4f6f-94ed-0332c9173817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e903c819-46f4-4e43-9447-b811e0ef64a9" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_16b24794-3aea-4f6f-94ed-0332c9173817" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mdgl-20240930.xsd#AccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3fd163bd-d6f9-4c02-8922-c14f5af782fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_622ef261-a6c9-4520-9265-981e81c3d7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3fd163bd-d6f9-4c02-8922-c14f5af782fa" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_622ef261-a6c9-4520-9265-981e81c3d7c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedLiabilitiesGross_1511c43b-5148-4267-aaa8-41e82eb0164a" xlink:href="mdgl-20240930.xsd#mdgl_AccruedLiabilitiesGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3fd163bd-d6f9-4c02-8922-c14f5af782fa" xlink:to="loc_mdgl_AccruedLiabilitiesGross_1511c43b-5148-4267-aaa8-41e82eb0164a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedOtherClinicalStudyRelatedCostsCurrent_01dbb123-2a88-4b6f-8ca6-9b5417e29d3f" xlink:href="mdgl-20240930.xsd#mdgl_AccruedOtherClinicalStudyRelatedCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3fd163bd-d6f9-4c02-8922-c14f5af782fa" xlink:to="loc_mdgl_AccruedOtherClinicalStudyRelatedCostsCurrent_01dbb123-2a88-4b6f-8ca6-9b5417e29d3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_89058218-d821-4a2b-a6ff-87394ef4a025" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3fd163bd-d6f9-4c02-8922-c14f5af782fa" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_89058218-d821-4a2b-a6ff-87394ef4a025" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c316bdc8-38a8-4411-900d-0fa2671b4d12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3fd163bd-d6f9-4c02-8922-c14f5af782fa" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c316bdc8-38a8-4411-900d-0fa2671b4d12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedContractResearchCostsCurrent_8ac6d387-9941-4e39-b1ae-eb0c918453ff" xlink:href="mdgl-20240930.xsd#mdgl_AccruedContractResearchCostsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3fd163bd-d6f9-4c02-8922-c14f5af782fa" xlink:to="loc_mdgl_AccruedContractResearchCostsCurrent_8ac6d387-9941-4e39-b1ae-eb0c918453ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedManufacturingAndDrugSupplyCurrent_49505afb-93f8-4cfe-85f3-68b6190bf34a" xlink:href="mdgl-20240930.xsd#mdgl_AccruedManufacturingAndDrugSupplyCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_3fd163bd-d6f9-4c02-8922-c14f5af782fa" xlink:to="loc_mdgl_AccruedManufacturingAndDrugSupplyCurrent_49505afb-93f8-4cfe-85f3-68b6190bf34a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="mdgl-20240930.xsd#LongTermDebtMaturitiesofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a418153e-26c4-4be9-9106-197716b74971" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_LongTermDebtMaturityAfterYearTwo_d29f112e-9426-4619-a361-f4dec46837bc" xlink:href="mdgl-20240930.xsd#mdgl_LongTermDebtMaturityAfterYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a418153e-26c4-4be9-9106-197716b74971" xlink:to="loc_mdgl_LongTermDebtMaturityAfterYearTwo_d29f112e-9426-4619-a361-f4dec46837bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_aa673788-d9ca-4780-a6f5-1174efc218b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a418153e-26c4-4be9-9106-197716b74971" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_aa673788-d9ca-4780-a6f5-1174efc218b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_df090297-ec45-4504-9ef0-1b16b2a1816e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a418153e-26c4-4be9-9106-197716b74971" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_df090297-ec45-4504-9ef0-1b16b2a1816e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6ac323e9-26bf-40cf-8f4a-660092f53d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a418153e-26c4-4be9-9106-197716b74971" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6ac323e9-26bf-40cf-8f4a-660092f53d0f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
